Save time and get answers to complex questions with AI chat
Symbravo ingredients mechanism of action?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Are there specific stretches to avoid while on lipitor?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Allergan's patent for latisse expired?
See the DrugPatentWatch profile for Apalutamide
Apalutamide contains a diazaspiro[3.4]octane core. The patent literature from Janssen and affiliates describes several ways to make that diazaspiro[3.4]octane fragment and then elaborates it into the final apalutamide structure. If you’re after a patent-level description, here’s how it’s typically discussed in public patents (high level, not step-by-step conditions): - Core idea: form a spiro connection between two nitrogen-containing rings (a three-member and a four-member ring) to give the diazaspiro[3.4]octane framework, then install the aryl substituents and the thioamide/amide linkages that characterize apalutamide. - General synthetic themes you’ll see in the patents: - Construction of the diazaspiro core by linking a suitable diamine fragment with a cyclobutanone-derived fragment to forge the spiro center. - Use of protecting groups and selective deprotections to enable sequential installation of the two arylamido/thioamide substituents. - Late-stage functionalization to attach the fluorinated phenyl and trifluoromethyl aryl fragments that are characteristic of apalutamide. - What to look for in patent documents: - Claims directed to the diazaspiro[3.4]octane scaffold itself. - Schemes showing spirocyclization steps to assemble the two rings around a shared spiro carbon. - Subsequent steps that convert the spiro intermediate into the final apalutamide structure (aryl amide/thioamide assembly, N-alkylation, etc.). If you’d like, I can: - Gather the exact patent numbers and provide a concise, scheme-by-scheme summary of the routes to the diazaspiro[3.4]octane core used for apalutamide. - Pull out the key reagents/conditions described (at a high level) without giving sensitive experimental details. - Provide search terms and pointers to databases (Google Patents, Espacenet, USPTO) so you can review the schemes directly. Would you like me to locate the specific patent documents (and numbers) and summarize the main schemes? If you have any patent numbers or a country/jurisdiction preference, share them and I’ll tailor the summary.
Other Questions About Apalutamide :